Genesystem Co., Ltd. (KOSDAQ: 363250)
South Korea
· Delayed Price · Currency is KRW
8,820.00
-230.00 (-2.54%)
Dec 19, 2024, 1:59 PM KST
Genesystem Ratios and Metrics
Market cap in millions KRW. Fiscal year is January - December.
Millions KRW. Fiscal year is Jan - Dec.
| Current | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
| Dec '24 Dec 18, 2024 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 |
| Market Capitalization | 60,763 | 58,004 | 78,767 | - | - |
| Market Cap Growth | 225.87% | -26.36% | - | - | - |
| Enterprise Value | 48,129 | 33,431 | 46,228 | - | - |
| Last Close Price | 8640.00 | 8370.00 | 11450.00 | - | - |
| PE Ratio | - | - | 22.18 | - | - |
| PS Ratio | 38.27 | 15.88 | 5.95 | - | - |
| PB Ratio | 2.09 | 1.65 | 1.79 | - | - |
| P/TBV Ratio | 5.85 | 1.68 | 1.82 | - | - |
| P/FCF Ratio | - | - | 119.03 | - | - |
| P/OCF Ratio | - | - | 79.91 | - | - |
| EV/Sales Ratio | 30.72 | 9.15 | 3.49 | - | - |
| EV/EBITDA Ratio | - | - | 17.96 | - | - |
| EV/EBIT Ratio | - | - | 20.40 | - | - |
| EV/FCF Ratio | -6.39 | - | 69.86 | - | - |
| Debt / Equity Ratio | 0.14 | 0.12 | 0.09 | 0.32 | -0.57 |
| Debt / EBITDA Ratio | - | - | 1.60 | 1.09 | - |
| Debt / FCF Ratio | - | - | 6.24 | - | - |
| Asset Turnover | 0.04 | 0.08 | 0.38 | 1.27 | - |
| Inventory Turnover | 0.76 | 1.05 | 3.18 | 5.10 | - |
| Quick Ratio | 8.22 | 13.76 | 15.03 | 3.72 | 0.12 |
| Current Ratio | 10.40 | 15.49 | 15.70 | 4.28 | 0.15 |
| Return on Equity (ROE) | -32.70% | -22.72% | 12.59% | -337.80% | - |
| Return on Assets (ROA) | -13.92% | -8.99% | 4.07% | 20.07% | - |
| Return on Capital (ROIC) | -14.67% | -9.44% | 4.39% | 36.44% | - |
| Earnings Yield | -18.79% | -15.51% | 4.51% | - | - |
| FCF Yield | -12.39% | -11.47% | 0.84% | - | - |
| Buyback Yield / Dilution | -1.05% | -7.66% | -69.48% | -71.10% | - |
| Total Shareholder Return | -1.05% | -7.66% | -69.48% | -71.10% | - |
Source: S&P Capital IQ. Standard template.
Financial Sources.